{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:29:59Z","timestamp":1792092599418,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"crossref","award":["10-082982\/FSS"],"award-info":[{"award-number":["10-082982\/FSS"]}],"id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007405","name":"Hjerteforeningen","doi-asserted-by":"publisher","award":["10-04-R78-A278622613"],"award-info":[{"award-number":["10-04-R78-A278622613"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Faculty of Health and Medical Sciences","award":["211-0730\/10-3012"],"award-info":[{"award-number":["211-0730\/10-3012"]}]},{"DOI":"10.13039\/501100010346","name":"Else og Mogens Wedell Wedellsborgs Fond","doi-asserted-by":"crossref","award":["1069"],"award-info":[{"award-number":["1069"]}],"id":[{"id":"10.13039\/501100010346","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009898","name":"Beckett-Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009898","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dyslipidaemia and low-grade inflammation are central in atherogenesis and linked to overweight and physical inactivity. Lifestyle changes are important in secondary prevention of coronary artery disease (CAD). We compared the effects of combined weight loss and interval training with interval training alone on physical fitness, body composition, dyslipidaemia and low-grade inflammation in overweight, sedentary participants with CAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Seventy CAD patients, BMI 28\u201340\u00a0kg\/m<jats:sup>2<\/jats:sup> and age 45\u201375\u00a0years were randomised to (1) 12\u00a0weeks\u2019 aerobic interval training (AIT) at 90% of peak heart rate three times\/week followed by 40\u00a0weeks\u2019 AIT twice weekly or (2) a low energy diet (LED) (800\u20131000\u00a0kcal\/day) for 8\u201310\u00a0weeks followed by 40\u00a0weeks\u2019 weight maintenance including AIT twice weekly and a high-protein\/low-glycaemic load diet. Effects of the intervention were evaluated by physical fitness, body weight and composition. Dyslipidaemia was described using both biochemical analysis of lipid concentrations and lipoprotein particle subclass distribution determined by density profiling. Low-grade inflammation was determined by C-reactive protein, soluble urokinase-type plasminogen activator receptor and tumour necrosis factor \u03b1. Effects on continuous outcomes were tested by mixed-models analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-six (74%) AIT and 29 (83%) LED\u2009+\u2009AIT participants completed the study. At baseline subject included 43 (78%) men; subjects averages were: age 63\u00a0years (6.2), body weight 95.9\u00a0kg (12.2) and VO<jats:sub>2<\/jats:sub>peak 20.7\u00a0mL O<jats:sub>2<\/jats:sub>\/kg\/min (4.9). Forty-six (84%) had pre-diabetes (i.e. impaired fasting glucose and\/or impaired glucose tolerance). LED\u2009+\u2009AIT reduced body weight by 7.2\u00a0kg (\u2212\u20098.4; \u2212\u20096.1) and waist circumference by 6.6\u00a0cm (\u2212\u20097.7; \u2212\u20095.5) compared to 1.7\u00a0kg (\u2212\u20090.7; \u2212\u20092.6) and 3.3\u00a0cm (\u2212\u20095.1; \u2212\u20091.5) after AIT (within-group p\u2009&lt;\u20090.001, between-group p\u2009&lt;\u20090.001 and p\u2009=\u20090.018, respectively). Treatments caused similar changes in VO<jats:sub>2<\/jats:sub>peak and lowering of total cholesterol, triglycerides, non-HDL cholesterol and low-grade inflammation. A shift toward larger HDL particles was seen following LED\u2009+\u2009AIT while AIT elicited no change.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Both interventions were feasible. Both groups obtained improvements in VO<jats:sub>2<\/jats:sub>peak, serum-lipids and inflammation with superior weight loss and greater central fat loss following LED\u2009+\u2009AIT. Combined LED induced weight loss and exercise can be recommended to CAD patients.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> NCT01724567, November 12, 2012, retrospectively registered (enrolment ended in April 2013).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-019-0934-x","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T14:09:18Z","timestamp":1569938958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Effects of 1\u00a0year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial"],"prefix":"10.1186","volume":"18","clinical-trial-number":[{"clinical-trial-number":"nct01724567","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0669-8855","authenticated-orcid":false,"given":"Lene R\u00f8rholm","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus Huan","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Anholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Astrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Eugen-Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mogens","family":"Fenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary L.","family":"Walzem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen Bendix","family":"Haugaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"key":"934_CR1","first-page":"1","volume":"2016","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, et al. European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2016;2016:1\u201378.","journal-title":"Eur Heart J"},{"key":"934_CR2","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","volume":"67","author":"HB Hubert","year":"1983","unstructured":"Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968\u201377.","journal-title":"Circulation"},{"key":"934_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jacc.2012.10.035","volume":"61","author":"T Coutinho","year":"2013","unstructured":"Coutinho T, Goel K, de Corr\u00eaa S\u00e1 D, et al. Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of \u201cnormal weight central obesity\u201d. J Am Coll Cardiol. 2013;61:553\u201360.","journal-title":"J Am Coll Cardiol"},{"key":"934_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","volume":"67","author":"L Anderson","year":"2016","unstructured":"Anderson L, Oldridge N, Thompson DR, et al. Exercise-based cardiac rehabilitation for coronary heart disease Cochrane systematic review and meta-analysis. J Am Coll Cardiol. 2016;67:1\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"934_CR5","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/2047487315569401","volume":"23","author":"K Kotseva","year":"2016","unstructured":"Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23:636\u201348.","journal-title":"Eur J Prev Cardiol"},{"key":"934_CR6","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"G Hansson","year":"2005","unstructured":"Hansson G, Kriszbacher I, Kopp\u00e1n M, B\u00f3dis J. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685\u201395.","journal-title":"N Engl J Med"},{"key":"934_CR7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/oby.2003.145","volume":"11","author":"T Pischon","year":"2003","unstructured":"Pischon T, Hankinson S, Hotamisligil GS, Rifai N, Rimm EB. Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. Obes Res. 2003;11:1055\u201363.","journal-title":"Obes Res"},{"key":"934_CR8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/eurheartj\/eht367","volume":"35","author":"S Kaptoge","year":"2014","unstructured":"Kaptoge S, Seshasai SRK, Gao P, et al. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J. 2014;35:578\u201389.","journal-title":"Eur Heart J"},{"key":"934_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","volume":"268","author":"J Eugen-Olsen","year":"2010","unstructured":"Eugen-Olsen J, Andersen O, Linneberg A, et al. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med. 2010;268:296\u2013308.","journal-title":"J Intern Med"},{"key":"934_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijcard.2012.01.008","volume":"167","author":"AP van de Woestijne","year":"2013","unstructured":"van de Woestijne AP, Wassink AMJ, Monajemi H, et al. Plasma triglyceride levels increase the risk for recurrent vascular events independent of LDL-cholesterol or nonHDL-cholesterol. Int J Cardiol. 2013;167:403\u20138.","journal-title":"Int J Cardiol"},{"key":"934_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jacc.2009.07.057","volume":"55","author":"BJ Arsenault","year":"2009","unstructured":"Arsenault BJ, Rana JS, Stroes ESG, et al. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol\/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healt. J Am Coll Cardiol. 2009;55:35\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"934_CR12","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1093\/eurheartj\/eht022","volume":"34","author":"PM Ridker","year":"2013","unstructured":"Ridker PM, Kastelein JJP, Genest J, Koenig W. C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care. Eur Heart J. 2013;34:1258\u201361.","journal-title":"Eur Heart J"},{"key":"934_CR13","doi-asserted-by":"publisher","first-page":"e001118","DOI":"10.1161\/JAHA.114.001118","volume":"3","author":"DJ Eapen","year":"2014","unstructured":"Eapen DJ, Manocha P, Ghasemzedah N, et al. Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events. J Am Heart Assoc. 2014;3:e001118.","journal-title":"J Am Heart Assoc"},{"key":"934_CR14","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","volume":"349","author":"E Haverkate","year":"1997","unstructured":"Haverkate E, Thompson S, Pyke S, Gallimore J, Pepys M. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462\u20136.","journal-title":"Lancet"},{"key":"934_CR15","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1161\/01.CIR.101.18.2149","volume":"101","author":"PM Ridker","year":"2000","unstructured":"Ridker PM, Rifai N, Pfeffer M, et al. Elevation of tumor necrosis factor-\u03b1 and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000;101:2149\u201353.","journal-title":"Circulation"},{"key":"934_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1476-511X-10-119","volume":"10","author":"K Varady","year":"2011","unstructured":"Varady K, Bhutani S, Klempel MC, Kroeger CM. Comparison of effects of diet versus exercise weight loss regimens on LDL and HDL particle size in obese adults. Lipids Health Dis. 2011;10:119.","journal-title":"Lipids Health Dis"},{"key":"934_CR17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJM198811033191801","volume":"319","author":"P Wood","year":"1988","unstructured":"Wood P, Stefanick M, Dreon D, et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med. 1988;319:1173\u20139.","journal-title":"N Engl J Med"},{"key":"934_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.atherosclerosis.2015.10.018","volume":"243","author":"MA Sarzynski","year":"2015","unstructured":"Sarzynski MA, Burton J, Rankinen T, et al. The effects of exercise on the lipoprotein subclass profile: a meta-analysis of 10 interventions. Atherosclerosis. 2015;243:364\u201372.","journal-title":"Atherosclerosis"},{"key":"934_CR19","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMoa020194","volume":"347","author":"WE Kraus","year":"2002","unstructured":"Kraus WE, Houmard J, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002;347:1483\u201392.","journal-title":"N Engl J Med"},{"key":"934_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ahj.2006.04.019","volume":"152","author":"K Huffman","year":"2006","unstructured":"Huffman K, Samsa G, Slentz C, et al. Response of high-sensitivity C-reactive protein to exercise training in an at-risk population. Am Heart J. 2006;152:793\u2013800.","journal-title":"Am Heart J"},{"key":"934_CR21","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.ahj.2011.12.017","volume":"163","author":"W Swardfager","year":"2012","unstructured":"Swardfager W, Herrmann N, Cornish S, et al. Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis. Am Heart J. 2012;163:666\u201376.","journal-title":"Am Heart J"},{"key":"934_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/archinte.167.1.31","volume":"167","author":"E Selvin","year":"2007","unstructured":"Selvin E, Paynter N, Erlinger T. The effect of weight loss on c-reactive protein. Arch Intern Med. 2007;167:31\u20139.","journal-title":"Arch Intern Med"},{"key":"934_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0065-2423(08)00408-3","volume":"46","author":"A Ellington","year":"2008","unstructured":"Ellington A, Kullo I. Atherogenic lipoprotein subprofiling. Adv Clin Chem. 2008;46:295\u2013317.","journal-title":"Adv Clin Chem"},{"key":"934_CR24","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1161\/STROKEAHA.112.664094","volume":"43","author":"A Edsfeldt","year":"2012","unstructured":"Edsfeldt A, Nitulescu M, Grufman H, et al. Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque. Stroke. 2012;43:3305\u201312.","journal-title":"Stroke"},{"key":"934_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-017-0590-y","volume":"16","author":"C Ostman","year":"2017","unstructured":"Ostman C, Smart NA, Morcos D, et al. The effect of exercise training on clinical outcomes in patients with the metabolic syndrome: a systematic review and meta-analysis. Cardiovasc Diabetol. 2017;16:1\u201311.","journal-title":"Cardiovasc Diabetol"},{"key":"934_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-017-0518-6","volume":"16","author":"A Grace","year":"2017","unstructured":"Grace A, Chan E, Giallauria F, Graham PL, Smart NA. Clinical outcomes and glycaemic responses to different aerobic exercise training intensities in type II diabetes: a systematic review and meta-analysis. Cardiovasc Diabetol. 2017;16:1\u201310.","journal-title":"Cardiovasc Diabetol"},{"key":"934_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.7326\/0003-4819-133-2-200007180-00008","volume":"133","author":"R Ross","year":"2000","unstructured":"Ross R, Dagnone D, Jones PJHP, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in menA randomized, controlled trial. Ann Intern Med. 2000;133:92\u2013103.","journal-title":"Ann Intern Med"},{"key":"934_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.atherosclerosis.2016.01.001","volume":"246","author":"LR Pedersen","year":"2016","unstructured":"Pedersen LR, Olsen RH, Anholm C, et al. Weight loss is superior to exercise in improving the atherogenic lipid profile in a sedentary, overweight population with stable coronary artery disease: a randomized trial. Atherosclerosis. 2016;246:221\u20138.","journal-title":"Atherosclerosis"},{"key":"934_CR29","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1177\/2047487314545280","volume":"22","author":"LR Pedersen","year":"2015","unstructured":"Pedersen LR, Olsen RH, J\u00fcrs A, et al. A randomised trial comparing weight loss with aerobic exercise in overweight individuals with coronary artery disease: The CUT-IT trial. Eur J Prev Cardiol. 2015;22:1009\u201317.","journal-title":"Eur J Prev Cardiol"},{"key":"934_CR30","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1056\/NEJMoa1008234","volume":"364","author":"DT Villareal","year":"2011","unstructured":"Villareal DT, Chode S, Parimi N, et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med. 2011;364:1218\u201329.","journal-title":"N Engl J Med"},{"key":"934_CR31","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1161\/CIRCULATIONAHA.108.834184","volume":"119","author":"P Ades","year":"2009","unstructured":"Ades P, Savage PD, Toth MJ, et al. High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients. Circulation. 2009;119:2671\u20138.","journal-title":"Circulation"},{"key":"934_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/HJR.0b013e328336a05f","volume":"17","author":"D De Bacquer","year":"2010","unstructured":"De Bacquer D, Dallongeville J, Heidrich J, et al. Management of overweight and obese patients with coronary heart disease across Europe. Eur J Cardiovasc Prev Rehabil. 2010;17:447\u201354.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"934_CR33","first-page":"377","volume":"14","author":"G Borg","year":"1982","unstructured":"Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377\u201381.","journal-title":"Med Sci Sports Exerc"},{"key":"934_CR34","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1056\/NEJMoa1007137","volume":"363","author":"TM Larsen","year":"2010","unstructured":"Larsen TM, Dalskov S-M, van Baak M, et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med. 2010;363:2102\u201313.","journal-title":"N Engl J Med"},{"key":"934_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1471-2261-13-106","volume":"13","author":"LR Pedersen","year":"2013","unstructured":"Pedersen LR, Olsen RH, Frederiksen M, et al. Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol. BMC Cardiovasc Disord. 2013;13:106.","journal-title":"BMC Cardiovasc Disord"},{"key":"934_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1748-1716.1957.tb01383.x","volume":"38","author":"W von D\u00f6beln","year":"1956","unstructured":"von D\u00f6beln W. Maximal oxygen intake, body size, and total hemoglobin in normal man. Acta Physiol Scand. 1956;38:193\u20139.","journal-title":"Acta Physiol Scand"},{"key":"934_CR37","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, et al. International physical activity questionnaire: 12-Country reliability and validity. Med Sci Sports Exerc. 2003;35:1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"key":"934_CR38","unstructured":"Ipaq Research Committee. Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ)\u2014short and long forms. 2005:1\u201315."},{"key":"934_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1477-7525-1-29","volume":"1","author":"R Snaith","year":"2003","unstructured":"Snaith R. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1:29.","journal-title":"Health Qual Life Outcomes"},{"key":"934_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1161\/01.ATV.15.3.299","volume":"15","author":"LI Katzel","year":"1995","unstructured":"Katzel LI, Coon PJ, Rogus E, Kraus RM, Goldberg AP. Persistence of low HDL-C levels after weight reduction in older men with small LDL particles. Arterioscler Thromb Vasc Biol. 1995;15:299\u2013305.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"934_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-018-0769-x","volume":"17","author":"H Amadid","year":"2018","unstructured":"Amadid H, Johansen NB, Bjerregaard AL, et al. The role of physical activity in the development of first cardiovascular disease event: a tree-structured survival analysis of the Danish ADDITION-PRO cohort. Cardiovasc Diabetol. 2018;17:1\u201312.","journal-title":"Cardiovasc Diabetol"},{"key":"934_CR42","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ahj.2008.03.017","volume":"156","author":"SJ Keteyian","year":"2008","unstructured":"Keteyian SJ, Brawner CA, Savage PD, et al. Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Am Heart J. 2008;156:292\u2013300.","journal-title":"Am Heart J"},{"key":"934_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1212914","volume":"369","author":"RR Wing","year":"2013","unstructured":"Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145\u201354.","journal-title":"N Engl J Med"},{"key":"934_CR44","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/ajcn\/84.6.1317","volume":"84","author":"DT Villareal","year":"2006","unstructured":"Villareal DT, Miller BV, Banks M, et al. Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. Am J Clin Nutr. 2006;84:1317\u201323.","journal-title":"Am J Clin Nutr"},{"key":"934_CR45","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1001\/archinte.166.8.860","volume":"166","author":"DT Villareal","year":"2006","unstructured":"Villareal DT, Banks M, Sinacore DR, Siener C, Klein S. Effect of weight loss and exercise on frailty in obese older adults. Arch Intern Med. 2006;166:860\u20136.","journal-title":"Arch Intern Med"},{"key":"934_CR46","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1152\/japplphysiol.00853.2006","volume":"102","author":"EP Weiss","year":"2007","unstructured":"Weiss EP, Racette SB, Villareal DT, et al. Lower extremity muscle size and strength and aerobic capacity decrease with caloric restriction but not with exercise-induced weight loss. J Appl Physiol. 2007;102:634\u201340.","journal-title":"J Appl Physiol"},{"key":"934_CR47","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.jacc.2012.05.037","volume":"60","author":"CJ Lavie","year":"2012","unstructured":"Lavie CJ, De Schutter A, Patel DA, et al. Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the \u201cobesity paradox\u201d. J Am Coll Cardiol. 2012;60:1374\u201380.","journal-title":"J Am Coll Cardiol"},{"key":"934_CR48","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05488","volume":"444","author":"J-P Despr\u00e9s","year":"2006","unstructured":"Despr\u00e9s J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881\u20137.","journal-title":"Nature"},{"key":"934_CR49","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s00125-019-4866-5","volume":"62","author":"S Lee","year":"2019","unstructured":"Lee S, Norheim F, Langleite TM, et al. Effects of long-term exercise on plasma adipokine levels and inflammation-related gene expression in subcutaneous adipose tissue in sedentary dysglycaemic, overweight men and sedentary normoglycaemic men of healthy weight. Diabetologia. 2019;62:1048\u201364.","journal-title":"Diabetologia"},{"key":"934_CR50","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1038\/oby.2009.146","volume":"17","author":"PW Siri-Tarino","year":"2009","unstructured":"Siri-Tarino PW, Williams PT, Fernstrom HS, Rawlings RS, Krauss RM. Reversal of small, dense LDL subclass phenotype by normalization of adiposity. Obesity. 2009;17:1768\u201375.","journal-title":"Obesity"},{"key":"934_CR51","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.113.002671","volume":"128","author":"S Mora","year":"2013","unstructured":"Mora S, Glynn RJ, Ridker PM. High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation. 2013;128:1189\u201397.","journal-title":"Circulation"},{"key":"934_CR52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10557-006-8283-x","volume":"20","author":"M Rizzo","year":"2006","unstructured":"Rizzo M, Berneis K. The clinical relevance of low-density-lipoproteins size modulation by statins. Cardiovasc Drugs Ther. 2006;20:205\u201317.","journal-title":"Cardiovasc Drugs Ther"},{"key":"934_CR53","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1053\/euhj.2002.3239","volume":"23","author":"V Conraads","year":"2002","unstructured":"Conraads V, Beckers P, Bosmans J, et al. Combined endurance\/resistance training reduces plasma TNF-\u03b1 receptor levels in patients with chronic heart failure and coronary artery disease. Eur Heart J. 2002;23:1854\u201360.","journal-title":"Eur Heart J"},{"key":"934_CR54","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/17461391.2017.1359679","volume":"17","author":"CA Vella","year":"2017","unstructured":"Vella CA, Taylor K, Drummer D. High-intensity interval and moderate-intensity continuous training elicit similar enjoyment and adherence levels in overweight and obese adults. Eur J Sport Sci. 2017;17:1203\u201311.","journal-title":"Eur J Sport Sci"},{"key":"934_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/JIR.S54360","volume":"7","author":"MR Mouridsen","year":"2014","unstructured":"Mouridsen MR, Nielsen OW, Carlsen CM, et al. High-sensitivity C-reactive protein and exercise-induced changes in subjects suspected of coronary artery disease. J Inflamm Res. 2014;7:45\u201355.","journal-title":"J Inflamm Res"},{"key":"934_CR56","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1161\/CIRCULATIONAHA.111.033274","volume":"124","author":"O G\u00f6gebakan","year":"2011","unstructured":"G\u00f6gebakan O, Kohl A, Osterhoff MA, et al. Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial. Circulation. 2011;124:2829\u201338.","journal-title":"Circulation"},{"issue":"3","key":"934_CR57","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jsams.2017.06.018","volume":"21","author":"C Rohde","year":"2018","unstructured":"Rohde C, Polcwiartek C, Andersen E, Vang T, Nielsen J. Effect of a physical activity intervention on suPAR levels: a randomized controlled trial. J Sci Med Sport. 2018;21(3):286\u201390.","journal-title":"J Sci Med Sport"},{"key":"934_CR58","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4137\/BMI.S19876","volume":"9","author":"TH Haupt","year":"2014","unstructured":"Haupt TH, Kallemose T, Ladelund S, et al. Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population. Biomark Insights. 2014;9:91\u2013100.","journal-title":"Biomark Insights"},{"key":"934_CR59","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ijcard.2012.03.040","volume":"167","author":"S Lyngb\u00e6k","year":"2013","unstructured":"Lyngb\u00e6k S, Sehestedt T, Marott JL, et al. CRP and suPAR are differently related to anthropometry and subclinical organ damage. Int J Cardiol. 2013;167:781\u20135.","journal-title":"Int J Cardiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-019-0934-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:16:14Z","timestamp":1628612174000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-019-0934-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1186\/s12933-019-0934-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]},"assertion":[{"value":"15 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study adheres to the Helsinki declaration and was approved by the Ethics Committee of the Capital Region of Denmark (H-4-2010-146) and the Danish Dataprotection Agency. All participants gave oral informed consent and signed written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JEO is a founder, shareholder and board member of ViroGates A\/S, Denmark, the company that produces the suPARnostic<sup>\u00ae<\/sup> assay. JEO and SBH are inventors on a patent on suPAR and risk. Hvidovre Hospital, University of Copenhagen, Denmark, owns the patent, which is licensed to ViroGates A\/S. The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}